Journal article

The comparative effects of intensive glucose lowering in diabetes patients aged below or above 65 years: Results from the ADVANCE trial

Toshiaki Ohkuma, John Chalmers, Mark Cooper, Pavel Hamet, Stephen Harrap, Michel Marre, Giuseppe Mancia, Neil Poulter, Mark Woodward

DIABETES OBESITY & METABOLISM | WILEY | Published : 2021

Abstract

AIMS: For relatively old patients with diabetes, current guidelines recommend adjustment of glycaemic goals based on patients' cognitive function, or coexisting chronic illnesses. However, the evidence which supports the efficacy and safety of intensive glucose lowering in older patients with diabetes is scarce. The objective of the present study was to compare the efficacy and safety of intensive glucose lowering in patients with type 2 diabetes stratified by age (<65 and ≥ 65 years), and examine whether the effects differ according to patients' characteristics in the older patient group. MATERIALS AND METHODS: The effects of intensive glucose lowering (to a target glycated haemoglobin [HbA..

View full abstract

University of Melbourne Researchers